| Dec 2, 2014
| 11:28 AM
Avanir Pharmaceuticals Inc. in Aliso Viejo said Tuesday that it has agreed to be acquired by Japanese drug giant Otsuka Pharmaceutical Co. for about $3.5 billion in cash, the latest in a string of mergers sweeping the healthcare sector.
Otsuka, a unit...
| Dec 4, 2014
| 11:48 AM
A Los Angeles seafood company specializing in smoked and pickled fish was ordered shut by a federal judge over unsanitary conditions.
Neptune Manufacturing Inc. can’t reopen until it meets compliance with the U.S. Food and Drug Administration....
| Dec 4, 2014
| 6:00 PM
Express Scripts, which handles prescription-drug benefits for millions or people nationwide, is dropping coverage for 66 brand-name drugs next month in an effort to keep costs down. Rival CVS Health is dropping 95 drugs from its own list of covered drugs....
| Dec 1, 2014
| 2:49 AM
There's yet another pharmaceutical campaign on the offensive, hoping to convince women with sexual problems that a drug called Flibanserin will cure them. This compound is a central nervous system formula originally studied as a remedy for depression....
| Dec 10, 2014
| 2:30 AM
Trying to save money on prescription drugs can be enough to make you reach for the pain pills. Navigating the annual changes to your health plan, figuring out insurance co-pays, and finding the pharmacy with the best buys can be daunting. And if you're on...
| Nov 15, 2014
| 10:11 PM
The company at the center of a probe into why more than a dozen women died after being sterilized in India has denied that the antibiotic tablets it manufactured were contaminated with a chemical compound commonly found in rat poison.
| Nov 24, 2014
| 6:41 PM
— Wall Street's big business — helping companies buy other companies — is hotter than it's been in years.
When pharmaceuticals giant Actavis said it was buying Allergan Inc. in Irvine and Halliburton said it would take over rival oil-...
| Nov 16, 2014
| 6:08 PM
Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world's most tenacious diseases.
The Pasadena biopharmaceutical company is developing so-called RNAi therapeutics. Such...
| Nov 17, 2014
Twenty years ago Jeff Baker started a promotional product company in a spare bedroom in his home in Indianapolis.
Today, that business, called Noble, has turned into a privately held multimillion-dollar niche product manufacturing company that takes...
| Nov 17, 2014
| 8:30 PM
Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion.
The deal thwarts a...
| Nov 18, 2014
| 3:18 PM
Ingredion said Tuesday its annual sales should hit $8 billion by 2019, up from $6.33 billion last year, as the ingredients-maker pushes to notch more sales from fast-growing specialty products and international markets.
The announcement comes weeks after...